Quick detection of Legionella IgM antibodies
Legionella pneumophila is responsible for at least two diseases in humans: Legionnaires’ disease, which is a severe form of pneumonia, clinically indistinguishable from other types of bacterial pneumonia, and Pontiac fever which is a flu-like illness. Legionella pneumophila is often associated with systemic manifestations and is responsible for up to 10% of hospitalized pneumonia cases acquired in the community. Statens Serum Institut has developed Immuview® Legionella Blood Test which is a lateral flow test for identification of IgM against Legionella pneumophila serogroup 1 and 3. It has been developed as a test primarily for patients with severe pneumonia; who have travelled abroad or been in areas with outbreak of Legionella; who have had indications of Legionella in a urine test; who have caught pneumonia when hospitalized. The Immuview® Legionella Blood test makes it possible to identify IgM antibodies against Legionella pneumophila serogroup 1 and 3 early in the course of the illness, and at the stage when the patient is normally admitted to the hospital. The test contains Legionella pneumophila serogroup 1 and 3 antigens, which have been applied to a lateral flow membrane. The test is simple to use and shows a result within 20 minutes. A drop of blood is added to the sample port, and a minute later four drops of running buffer is added to the buffer addition port. After 20 minutes the result can be read. ImmuView™ Legionella Blood Test is sold in kits of 10 or 50 tests including buffer, a positive control, and a score card for semi quantitative measuring.
Supplier: SSI Diagnostica A/S
Website:
